marketcaparena
Search

    MDXG

    MIMEDX GROUP, INC.

    Company overview

    Market capitalization
    $682.16M
    Employees
    808
    Latest publication
    2026-09-29
    About MIMEDX GROUP, INC.

    MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company processes the human placental tissues membrane, and umbilical cord and the placental disc utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins, including cytokines, chemokines, and growth factors. Its patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. The company's wound care products include EPIFIX, EPICORD, EPIXPRESS, CHORIOFIX, EMERGE, CELERA, REGENKIT WOUND GEL, and EPIEFFECT sheets for use as protective barriers that enables a healthcare provider to select an appropriate size graft based on the size of the wound to reduce product waste. Its surgical and other product offerings consist of AMNIOFIX, AMNIOBURN, AMNIOCORD, AXIOFILL, HELIOGEN, and AMNIOEFFECT for applications in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery, and various orthopedic repairs and reconstructions. The company's products are used in the areas of wound care, burn, and surgical fields in healthcare. It sells its products through direct sales force and independent sales agents, as well as to individual customers and independent distributors in the United States. The company has a strategic alliance with Vaporox, Inc. for the promotion of their wound care offerings. The company was founded in 2006 and is headquartered in Marietta, Georgia.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Total Revenue64,362,000USD118,095,000USD113,725,000USD98,605,000USD88,205,000USD92,907,000USD84,057,000USD87,207,000USD
    Cost Of Revenue19,981,000USD19,055,000USD18,719,000USD18,681,000USD16,558,000USD16,909,000USD15,322,000USD15,045,000USD
    Gross Profit44,381,000USD99,040,000USD95,006,000USD79,924,000USD71,647,000USD75,998,000USD68,735,000USD72,162,000USD
    Research Development2,777,000USD4,763,000USD3,703,000USD3,303,000USD3,328,000USD3,571,000USD2,918,000USD3,012,000USD
    Selling General Administrative59,779,000USD73,073,000USD15,281,000USD16,284,000USD59,969,000USD61,043,000USD53,516,000USD55,401,000USD
    Other Operating Expenses291,000USD———————
    Total Operating Expenses62,847,000USD77,836,000USD72,816,000USD67,554,000USD63,396,000USD64,944,000USD57,573,000USD48,902,000USD
    Operating Income-18,466,000USD21,076,000USD22,190,000USD12,370,000USD8,250,999USD11,054,000USD11,162,000USD23,450,000USD
    Total Other Income Expense Net686,000USD718,000USD659,000USD637,000USD361,000USD195,000USD257,000USD-234,000USD
    Income Before Tax-17,780,000USD21,795,000USD22,849,000USD13,007,000USD8,612,000USD11,249,000USD11,419,000USD23,216,000USD
    Income Tax Expense-2,940,000USD6,605,000USD6,101,000USD3,389,000USD1,589,000USD3,811,000USD3,541,000USD5,595,000USD
    Net Income-14,840,000USD15,189,000USD16,748,000USD9,618,000USD7,023,000USD7,438,000USD8,095,000USD17,625,000USD
    Interest Expense—405,000USD785,000USD475,000USD478,000USD2,529,000USD278,000USD3,000USD
    Net Interest Income—904,000USD785,000USD738,000USD506,000USD403,000USD278,000USD3,000USD
    Tax Provision—6,604,000USD6,101,000USD3,389,000USD1,589,000USD3,811,000USD3,541,000USD5,595,000USD
    Net Income From Continuing Ops—15,191,000USD16,748,000USD9,618,000USD7,023,000USD7,438,000USD7,878,000USD17,621,000USD
    Ebit—22,199,000USD23,634,000USD13,482,000USD9,090,000USD11,148,000USD11,460,000USD23,219,000USD
    Ebitda—25,419,000USD28,924,000USD16,626,000USD12,317,000USD14,138,000USD12,615,000USD24,346,000USD
    Depreciation And Amortization—3,220,000USD5,290,000USD3,144,000USD3,227,000USD2,990,000USD1,155,000USD1,127,000USD
    Reconciled Depreciation—3,220,000USD5,290,000USD3,168,000USD3,203,000USD2,990,000USD1,155,000USD1,149,000USD
    Selling And Marketing Expenses——53,720,000USD47,867,000USD————
    Interest Income——785,000USD—984,000USD—278,000USD—
    Unclassified Operating Expenses——————1,139,000USD-9,511,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20172017-12-31 · USDFY 20152015-12-31 · USDFY 20142014-12-31 · USDFY 20092009-12-31 · USDFY 20082008-12-31 · USD
    Total Revenue418,630,000USD348,879,000USD321,477,000USD321,139,000USD187,296,000USD118,223,000USD——
    Cost Of Revenue73,013,000USD60,073,000USD54,634,000USD35,219,000USD20,202,000USD12,665,000USD——
    Gross Profit345,617,000USD288,806,000USD266,843,000USD285,920,000USD167,094,000USD105,558,000USD——
    Research Development15,097,000USD12,341,000USD12,665,000USD17,900,000USD8,413,000USD7,050,000USD4,022,709USD2,013,002USD
    Selling General Administrative266,194,000USD225,087,000USD206,724,000USD216,019,000USD133,384,000USD90,480,000USD7,956,113USD7,956,113USD
    Total Operating Expenses281,291,000USD229,941,000USD229,727,000USD239,697,000USD142,730,000USD98,458,000USD11,978,822USD10,672,407USD
    Operating Income63,887,000USD58,865,000USD37,116,000USD46,223,000USD24,364,000USD7,100,000USD-11,978,822USD-17,849,407USD
    Interest Expense1,783,000USD1,006,000USD6,457,000USD87,000USD86,000USD48,000USD0USD0USD
    Net Interest Income2,933,000USD-1,006,000USD-6,314,000USD-87,000USD————
    Income Before Tax66,262,000USD57,294,000USD30,633,000USD45,088,000USD24,278,000USD7,052,000USD-11,919,271USD-17,371,475USD
    Income Tax Expense17,684,000USD15,296,000USD-36,806,000USD-19,639,000USD-5,168,000USD832,000USD59,551USD-477,932USD
    Tax Provision17,684,000USD15,296,000USD597,000USD-19,639,000USD————
    Net Income48,578,000USD42,419,000USD67,439,000USD64,727,000USD29,446,000USD6,220,000USD-11,919,271USD-17,371,475USD
    Net Income From Continuing Ops48,578,000USD41,998,000USD4,337,000USD64,727,000USD29,446,000USD6,220,000USD——
    Ebit68,045,000USD59,311,000USD37,090,000USD46,813,000USD24,364,000USD7,100,000USD-11,978,822USD-11,327,704USD
    Ebitda82,926,000USD65,352,000USD40,517,000USD52,578,000USD27,096,000USD9,225,000USD-10,886,993USD-10,827,442USD
    Depreciation And Amortization14,881,000USD6,041,000USD3,427,000USD5,765,000USD2,732,000USD2,125,000USD1,091,829USD500,262USD
    Reconciled Depreciation14,881,000USD6,041,000USD3,602,000USD5,765,000USD————
    Total Other Income Expense Net2,375,000USD-1,571,000USD-6,483,000USD-1,135,000USD-86,000USD-48,000USD59,551USD-5,392,653USD
    Unclassified Operating Expenses—-7,487,000USD10,338,000USD5,778,000USD————
    Net Income Applicable To Common Shares———64,727,000USD29,446,000USD6,220,000USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets280,998,000USD308,676,000USD342,653,000USD318,988,000USD291,109,000USD270,420,000USD263,915,000USD243,891,000USD
    Cash And Equivalents135,839,000USD———————
    Total Current Assets205,365,000USD240,326,000USD277,471,000USD254,095,000USD220,876,000USD200,112,000USD191,886,000USD172,139,000USD
    Other Current Assets7,298,000USD8,291,000USD10,303,000USD7,324,000USD7,889,000USD7,323,000USD7,835,000USD5,059,000USD
    Other Non Current Assets11,897,000USD———————
    Total Liabilities64,995,000USD———————
    Total Current Liabilities38,498,000USD44,550,000USD64,266,000USD57,682,000USD50,290,000USD42,619,000USD45,595,000USD41,941,000USD
    Other Current Liabilities4,390,000USD———————
    Other Non Current Liabilities10,791,000USD———————
    Total Stockholder Equity216,003,000USD242,936,000USD256,548,000USD238,946,000USD216,624,000USD202,776,000USD193,107,000USD181,008,000USD
    Total Equity Including Noncontrolling Interest216,003,000USD———————
    Short Long Term Debt1,500,000USD1,500,000USD1,500,000USD1,375,000USD1,250,000USD1,125,000USD1,000,000USD1,000,000USD
    Long Term Debt15,706,000USD16,094,000USD16,467,000USD16,839,000USD17,211,000USD17,533,000USD17,830,000USD18,018,000USD
    Net Receivables41,297,000USD46,034,000USD75,707,000USD78,186,000USD69,228,000USD62,288,000USD55,828,000USD54,030,000USD
    Inventory20,931,000USD26,228,000USD25,340,000USD26,502,000USD24,890,000USD24,070,000USD23,807,000USD24,249,000USD
    Property Plant Equipment Net4,914,000USD4,756,000USD4,713,000USD9,671,000USD10,377,000USD11,072,000USD11,550,000USD9,294,000USD
    Goodwill19,441,000USD———————
    Intangible Assets12,086,000USD13,140,000USD14,158,000USD11,147,000USD12,028,000USD11,062,000USD11,626,000USD11,201,000USD
    Accounts Payable8,293,000USD11,464,000USD14,528,000USD11,415,000USD8,499,000USD8,868,000USD7,409,000USD6,924,000USD
    Common Stock149,000USD149,000USD148,000USD148,000USD148,000USD148,000USD147,000USD147,000USD
    Retained Earnings-68,381,000USD-53,541,000USD-42,681,000USD-57,872,000USD-74,620,000USD-84,236,000USD-91,259,000USD-98,697,000USD
    Total Liab—65,740,000USD86,105,000USD80,042,000USD74,485,000USD67,644,000USD70,808,000USD62,883,000USD
    Other Current Liab—31,586,000USD46,918,000USD44,892,000USD40,541,000USD32,626,000USD35,879,000USD34,017,000USD
    Capital Stock—149,000USD148,000USD148,000USD148,000USD148,000USD147,000USD147,000USD
    Good Will—19,441,000USD19,441,000USD19,441,000USD19,441,000USD19,441,000USD19,441,000USD19,441,000USD
    Cash—159,773,000USD166,121,000USD142,083,000USD118,869,000USD106,431,000USD104,416,000USD88,801,000USD
    Cash And Short Term Investments—159,773,000USD166,121,000USD142,083,000USD118,869,000USD106,431,000USD104,416,000USD88,801,000USD
    Net Debt—-142,179,000USD-143,589,000USD-123,869,000USD-100,408,000USD-87,773,000USD-79,574,000USD-69,783,000USD
    Short Term Debt—1,500,000USD2,820,000USD1,375,000USD1,250,000USD1,125,000USD2,307,000USD1,000,000USD
    Short Long Term Debt Total—17,594,000USD22,532,000USD18,214,000USD18,461,000USD18,658,000USD24,842,000USD19,018,000USD
    Property Plant Equipment Gross—28,616,000USD28,211,000USD32,643,000USD32,810,000USD32,943,000USD32,872,000USD30,562,000USD
    Common Stock Shares Outstanding—148,446,017shares149,724,507shares149,713,653shares149,317,281shares149,677,452shares149,049,197shares148,373,631shares
    Non Current Assets Total—68,350,000USD65,182,000USD64,893,000USD70,232,999USD70,308,000USD72,029,000USD71,752,000USD
    Non Current Liabilities Total—21,190,000USD21,839,000USD22,360,000USD24,195,000USD25,025,000USD25,213,000USD20,942,000USD
    Non Current Liabilities Other—5,096,000USD5,372,000USD5,521,000USD6,984,000USD7,492,000USD7,383,000USD2,924,000USD
    Non Currrent Assets Other—6,886,000USD7,274,000USD2,987,000USD989,999USD28,733,000USD1,106,000USD1,180,000USD
    Net Working Capital—195,776,000USD213,205,000USD196,413,000USD170,586,000USD157,493,000USD146,291,000USD130,198,000USD
    Unclassified Non Current Assets—24,127,000USD19,596,000USD21,647,000USD27,397,000USD—28,306,000USD30,636,000USD
    Unclassified Current Liabilities—-1,500,000USD-1,500,000USD-1,375,000USD-1,250,000USD-1,125,000USD——
    Unclassified Equity—296,179,000USD298,933,000USD296,522,000USD290,948,000USD286,716,000USD284,072,000USD279,411,000USD
    Accumulated Other Comprehensive Income—————0USD——
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets342,653,000USD263,915,000USD239,047,000USD171,430,000USD187,929,000USD202,032,000USD122,844,000USD122,844,000USD
    Intangible Assets14,158,000USD11,626,000USD5,257,000USD5,852,000USD5,383,000USD6,004,000USD9,608,000USD9,608,000USD
    Other Current Assets10,303,000USD7,835,000USD7,369,000USD11,981,000USD9,698,000USD19,021,000USD12,491,000USD5,818,000USD
    Total Liab86,105,000USD70,808,000USD96,330,000USD96,924,000USD95,353,000USD110,614,000USD73,189,000USD73,189,000USD
    Total Stockholder Equity256,548,000USD193,107,000USD142,717,000USD74,506,000USD92,576,000USD91,418,000USD49,655,000USD49,655,000USD
    Other Current Liab46,918,000USD35,879,000USD36,960,000USD33,663,000USD33,724,000USD49,221,000USD56,683,000USD29,765,000USD
    Common Stock148,000USD147,000USD146,000USD114,000USD113,000USD113,000USD113,000USD113,000USD
    Capital Stock148,000USD147,000USD146,000USD114,000USD92,607,000USD91,681,000USD113,000USD113,000USD
    Retained Earnings-42,681,000USD-91,259,000USD-133,678,000USD-191,906,000USD-161,709,000USD-151,424,000USD-76,560,000USD-76,560,000USD
    Good Will19,441,000USD19,441,000USD19,441,000USD19,441,000USD19,976,000USD19,976,000USD19,976,000USD19,976,000USD
    Cash166,121,000USD104,416,000USD82,000,000USD65,950,000USD87,083,000USD95,812,000USD45,118,000USD45,118,000USD
    Cash And Short Term Investments166,121,000USD104,416,000USD82,000,000USD65,950,000USD87,083,000USD95,812,000USD45,118,000USD45,118,000USD
    Total Current Assets277,471,000USD191,886,000USD164,261,000USD134,198,000USD148,523,000USD160,617,000USD74,049,000USD74,049,000USD
    Total Current Liabilities64,266,000USD45,595,000USD46,008,000USD43,557,000USD42,357,000USD59,162,000USD71,547,000USD71,547,000USD
    Net Debt-143,589,000USD-79,574,000USD-33,901,000USD-13,478,000USD-33,790,000USD-43,979,000USD-44,889,000USD-45,118,000USD
    Short Term Debt2,820,000USD2,307,000USD1,548,000USD1,440,000USD1,248,000USD1,176,000USD3,750,000USD—
    Short Long Term Debt1,500,000USD1,000,000USD1,000,000USD———3,750,000USD—
    Short Long Term Debt Total22,532,000USD24,842,000USD48,099,000USD52,472,000USD53,293,000USD51,833,000USD229,000USD—
    Long Term Debt16,467,000USD17,830,000USD48,099,000USD48,594,000USD48,127,000USD47,697,000USD61,906,000USD—
    Net Receivables75,707,000USD55,828,000USD53,871,000USD43,084,000USD40,353,000USD35,423,000USD454,000USD454,000USD
    Inventory25,340,000USD23,807,000USD21,021,000USD13,183,000USD11,389,000USD10,361,000USD15,986,000USD15,986,000USD
    Accounts Payable14,528,000USD7,409,000USD9,048,000USD8,454,000USD7,385,000USD8,765,000USD14,864,000USD14,864,000USD
    Property Plant Equipment Net4,713,000USD11,550,000USD9,106,000USD11,256,000USD13,861,000USD15,060,000USD17,424,000USD17,424,000USD
    Property Plant Equipment Gross28,211,000USD32,872,000USD29,134,000USD11,256,000USD13,861,000USD15,060,000USD17,424,000USD17,424,000USD
    Common Stock Shares Outstanding149,724,507shares149,049,000shares145,962,462shares112,909,266shares110,353,406shares108,257,112shares105,596,256shares109,098,663shares
    Non Current Assets Total65,182,000USD72,029,000USD74,786,000USD37,232,000USD39,406,000USD41,415,000USD48,795,000USD48,795,000USD
    Non Current Liabilities Total21,839,000USD25,213,000USD50,322,000USD53,367,000USD52,996,000USD51,452,000USD1,642,000USD1,642,000USD
    Non Current Liabilities Other5,372,000USD7,383,000USD2,223,000USD4,773,000USD4,869,000USD3,755,000USD3,540,000USD1,642,000USD
    Non Currrent Assets Other7,274,000USD1,106,000USD205,000USD683,000USD186,000USD375,000USD1,787,000USD1,787,000USD
    Net Working Capital213,205,000USD146,291,000USD118,253,000USD90,641,000USD106,166,000USD101,455,000USD55,923,000USD2,502,000USD
    Unclassified Non Current Assets19,596,000USD28,306,000USD40,777,000USD————-1,787,000USD
    Unclassified Current Liabilities-1,500,000USD—-2,548,000USD———-7,500,000USD26,918,000USD
    Unclassified Equity298,933,000USD284,072,000USD515,150,000USD266,184,000USD165,582,000USD158,497,000USD155,382,000USD183,218,000USD
    Current Deferred Revenue——-1,548,000USD-1,440,000USD-1,248,000USD-1,176,000USD——
    Accumulated Other Comprehensive Income——-239,047,000USD—0USD0USD-18,587,000USD-18,587,000USD
    Other Liab———2,335,000USD4,869,000USD3,755,000USD621,000USD1,642,000USD
    Other Assets———148,000USD186,000USD375,000USD443,000USD1,787,000USD
    Net Tangible Assets———-43,816,000USD-25,277,000USD91,418,000USD6,645,000USD20,071,000USD
    Unclassified Non Current Liabilities———-2,335,000USD-4,869,000USD-3,755,000USD-64,425,000USD-1,642,000USD
    Treasury Stock————-4,017,000USD-7,449,000USD-10,806,000USD-38,642,000USD
    Unclassified Current Assets———————6,673,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USDQ1 20242024-03-31 · USD
    Net Income-10,860,000USD16,748,000USD9,616,000USD7,023,000USD7,438,000USD7,878,000USD17,621,000USD9,061,000USD
    Depreciation1,617,000USD5,290,000USD3,168,000USD3,203,000USD2,990,000USD1,155,000USD1,149,000USD747,000USD
    Stock Based Compensation-1,696,000USD4,919,000USD4,752,000USD4,262,000USD4,693,000USD3,809,000USD4,091,000USD4,340,000USD
    Other Non Cash Items1,912,000USD2,623,000USD791,000USD1,215,000USD10,917,000USD546,000USD-8,648,000USD1,386,000USD
    Change To Account Receivables28,209,000USD-11,014,000USD-7,290,000USD-7,203,000USD-2,253,000USD-953,000USD3,998,000USD-3,344,000USD
    Change To Inventory-889,000USD-1,612,000USD-820,000USD-263,000USD440,000USD807,000USD-663,000USD-2,941,000USD
    Change In Working Capital15,437,000USD-6,002,000USD-4,195,000USD-11,025,000USD427,000USD3,431,000USD2,295,000USD-11,587,000USD
    Total Cash From Operating Activities1,879,000USD29,329,000USD14,419,000USD5,299,000USD18,782,000USD19,624,000USD21,814,000USD5,978,000USD
    Capital Expenditures-570,000USD-3,919,000USD-216,000USD-377,000USD-263,000USD-5,223,000USD-419,000USD-6,144,000USD
    Free Cash Flow1,309,000USD25,410,000USD14,203,000USD4,922,000USD18,519,000USD14,401,000USD21,395,000USD-166,000USD
    Total Cashflows From Investing Activities-5,642,000USD-5,258,000USD-887,000USD-406,000USD-2,767,000USD113,000USD-905,000USD-6,024,000USD
    Net Borrowings-375,000USD-250,000USD-250,000USD-250,000USD-232,000USD-251,000USD——
    Total Cash From Financing Activities-2,585,000USD-857,000USD-1,094,000USD-2,878,000USD-400,000USD27,000USD-359,000USD-33,467,000USD
    Sale Purchase Of Stock-1,901,000USD-83,000USD-526,000USD-2,458,000USD-30,000USD-110,000USD-349,000USD-2,152,000USD
    Change In Cash-6,348,000USD23,214,000USD12,438,000USD2,015,000USD15,615,000USD19,764,000USD20,550,000USD-33,513,000USD
    Begin Period Cash Flow166,121,000USD118,869,000USD106,431,000USD104,416,000USD88,801,000USD69,037,000USD48,487,000USD82,000,000USD
    End Period Cash Flow159,773,000USD142,083,000USD118,869,000USD106,431,000USD104,416,000USD88,801,000USD69,037,000USD48,487,000USD
    Other Cashflows From Investing Activities-72,000USD-5,066,000USD-8,000USD-29,000USD-2,767,000USD284,000USD-434,000USD-4,880,000USD
    Other Cashflows From Financing Activities-309,000USD-524,000USD-318,000USD-170,000USD963,000USD388,000USD244,000USD-335,000USD
    Unclassified Operating Cash Flow-4,531,000USD5,751,000USD——-7,683,000USD2,805,000USD5,306,000USD2,031,000USD
    Unclassified Investing Cash Flow-5,000,000USD8,985,000USD——3,030,000USD4,939,000USD—11,024,000USD
    Investments—-5,258,000USD-887,000USD-406,000USD-2,767,000USD113,000USD-905,000USD-6,024,000USD
    Unclassified Financing Cash Flow————-1,101,000USD——-30,980,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income48,578,000USD41,998,000USD67,439,000USD-30,197,000USD-12,301,000USD-25,580,000USD-29,979,000USD-29,979,000USD
    Depreciation14,881,000USD6,041,000USD3,427,000USD4,046,000USD5,183,000USD7,585,000USD6,916,000USD6,916,000USD
    Stock Based Compensation16,396,000USD16,933,000USD16,959,000USD12,666,000USD14,156,000USD12,064,000USD14,768,000USD—
    Other Non Cash Items8,418,000USD-5,812,000USD-4,832,000USD4,621,000USD10,332,000USD-15,004,000USD-53,000USD14,715,000USD
    Change To Account Receivables-26,394,000USD-2,552,000USD-12,237,000USD-5,550,000USD-10,620,000USD-10,938,000USD16,454,000USD-190,000USD
    Change To Inventory-1,533,000USD-2,357,000USD-7,838,000USD-1,794,000USD-1,406,000USD6,882,000USD-6,519,000USD-6,519,000USD
    Change In Working Capital-22,980,000USD-5,434,000USD-18,416,000USD-9,029,000USD-19,352,000USD-20,053,000USD18,603,000USD-435,000USD
    Total Cash From Operating Activities74,003,000USD66,198,000USD26,775,000USD-17,893,000USD-1,982,000USD-39,412,000USD35,796,000USD35,796,000USD
    Capital Expenditures-1,033,000USD-1,683,000USD-1,987,000USD-2,684,000USD-3,218,000USD-2,218,000USD-10,028,000USD-9,419,000USD
    Free Cash Flow72,970,000USD64,515,000USD24,788,000USD-20,577,000USD-5,200,000USD-41,630,000USD25,768,000USD25,768,000USD
    Total Cashflows From Investing Activities-6,886,000USD-9,583,000USD-2,155,000USD-2,660,000USD-3,395,000USD-4,555,000USD-9,220,000USD-9,220,000USD
    Net Borrowings-1,000,000USD-31,717,000USD0USD-41,000USD-38,000USD-29,046,000USD64,225,000USD-3,000USD
    Total Cash From Financing Activities-5,412,000USD-34,199,000USD-8,570,000USD-580,000USD-3,352,000USD62,859,000USD-8,934,000USD-8,934,000USD
    Sale Purchase Of Stock-3,118,000USD-2,641,000USD-9,515,000USD-1,190,000USD-4,751,000USD-1,474,000USD-12,486,000USD-4,017,000USD
    Change In Cash61,705,000USD22,416,000USD16,050,000USD-21,133,000USD-8,729,000USD23,951,000USD17,642,000USD17,642,000USD
    Begin Period Cash Flow104,416,000USD82,000,000USD65,950,000USD87,083,000USD95,812,000USD45,118,000USD27,476,000USD27,476,000USD
    End Period Cash Flow166,121,000USD104,416,000USD82,000,000USD65,950,000USD87,083,000USD69,069,000USD45,118,000USD45,118,000USD
    Other Cashflows From Investing Activities-2,089,000USD-38,000USD-168,000USD-1,146,000USD-177,000USD-327,000USD808,000USD-579,000USD
    Other Cashflows From Financing Activities-1,294,000USD159,000USD9,463,000USD651,000USD1,437,000USD66,208,000USD3,555,000USD36,166,000USD
    Unclassified Operating Cash Flow8,710,000USD12,472,000USD-37,802,000USD——1,576,000USD25,541,000USD44,579,000USD
    Unclassified Investing Cash Flow-3,764,000USD1,721,000USD3,383,000USD3,830,000USD3,395,000USD2,545,000USD-2,722,000USD—
    Investments—-9,583,000USD-3,383,000USD-2,660,000USD-3,395,000USD-4,555,000USD2,722,000USD778,000USD
    Dividends Paid——-997,000USD-651,000USD-1,437,000USD-100,000,000USD——
    Unclassified Financing Cash Flow——-7,521,000USD—1,437,000USD127,171,000USD-64,228,000USD-41,080,000USD
    Change To Liabilities———1,053,000USD-326,000USD205,000USD-8,945,000USD23,823,000USD
    Issuance Of Capital Stock———0USD0USD100,000,000USD——
    Cash And Cash Equivalents Changes————-8,729,000USD26,743,000USD23,951,000USD17,642,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30ProductSurgical39,297,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductWound25,065,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31ProductSurgical36,374,000USD0001376339-26-000031
    Q1 2026Quarterly · 2026-03-31ProductWound22,617,000USD0001376339-26-000031
    Q4 2025Quarterly · 2025-12-31ProductSurgical39,416,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductWound78,679,000USDLegacy provider
    FY 2025Yearly · 2025-12-31ProductSurgical142,304,000USD0001376339-26-000011
    FY 2025Yearly · 2025-12-31ProductWound276,326,000USD0001376339-26-000011
    Q3 2025Quarterly · 2025-09-30ProductSurgical36,627,000USD0001376339-25-000103
    Q3 2025Quarterly · 2025-09-30ProductWound77,098,000USD0001376339-25-000103
    Q2 2025Quarterly · 2025-06-30ProductSurgical34,129,000USD0001376339-25-000085
    Q2 2025Quarterly · 2025-06-30ProductWound64,476,000USD0001376339-25-000085
    Q1 2025Quarterly · 2025-03-31ProductSurgical32,132,000USD0001376339-26-000031
    Q1 2025Quarterly · 2025-03-31ProductWound56,073,000USD0001376339-26-000031
    Q4 2024Quarterly · 2024-12-31ProductSurgical31,550,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductWound61,356,000USDLegacy provider
    FY 2024Yearly · 2024-12-31ProductSurgical117,875,000USD0001376339-26-000011
    FY 2024Yearly · 2024-12-31ProductWound231,004,000USD0001376339-26-000011
    Q3 2024Quarterly · 2024-09-30ProductSurgical29,005,000USD0001376339-25-000103
    Q3 2024Quarterly · 2024-09-30ProductWound55,052,000USD0001376339-25-000103
    FY 2023Yearly · 2023-12-31ProductHospital Site Of Service187,000,000USD0001376339-24-000009
    FY 2023Yearly · 2023-12-31ProductOther Site Of Service38,688,000USD0001376339-24-000009
    FY 2023Yearly · 2023-12-31ProductPrivate Office Site Of Service95,789,000USD0001376339-24-000009
    Q3 2023Quarterly · 2023-09-30SegmentOther1,336,000USD0001376339-23-000069
    Q3 2023Quarterly · 2023-09-30SegmentRegenerative Medicine0USD0001376339-23-000069
    Q3 2023Quarterly · 2023-09-30SegmentWound Surgical80,376,000USD0001376339-23-000069
    Q2 2023Quarterly · 2023-06-30SegmentOther796,000USD0001376339-23-000063
    Q2 2023Quarterly · 2023-06-30SegmentRegenerative Medicine0USD0001376339-23-000063
    Q2 2023Quarterly · 2023-06-30SegmentWound Surgical80,461,000USD0001376339-23-000063
    Q1 2023Quarterly · 2023-03-31SegmentOther1,047,000USD0001376339-23-000015
    Q1 2023Quarterly · 2023-03-31SegmentRegenerative Medicine0USD0001376339-23-000015
    Q1 2023Quarterly · 2023-03-31SegmentWound Surgical70,629,000USD0001376339-23-000015
    FY 2022Yearly · 2022-12-31ProductHospital Site Of Service163,206,000USD0001376339-24-000009
    FY 2022Yearly · 2022-12-31ProductOther Site Of Service27,477,000USD0001376339-24-000009
    FY 2022Yearly · 2022-12-31ProductPrivate Office Site Of Service77,158,000USD0001376339-24-000009
    Q4 2022Quarterly · 2022-12-31SegmentOther766,000USDLegacy provider
    Q4 2022Quarterly · 2022-12-31SegmentRegenerative Medicine0USDLegacy provider
    Q4 2022Quarterly · 2022-12-31SegmentWound Surgical73,609,000USDLegacy provider
    FY 2022Yearly · 2022-12-31SegmentOther2,935,000USD0001376339-23-000003
    FY 2022Yearly · 2022-12-31SegmentRegenerative Medicine0USD0001376339-23-000003
    FY 2022Yearly · 2022-12-31SegmentWound Surgical264,906,000USD0001376339-23-000003
    Q3 2022Quarterly · 2022-09-30SegmentOther816,000USD0001376339-23-000069
    Q3 2022Quarterly · 2022-09-30SegmentRegenerative Medicine0USD0001376339-23-000069
    Q3 2022Quarterly · 2022-09-30SegmentWound Surgical66,873,000USD0001376339-23-000069
    Q2 2022Quarterly · 2022-06-30SegmentOther789,000USD0001376339-23-000063
    Q2 2022Quarterly · 2022-06-30SegmentRegenerative Medicine0USD0001376339-23-000063
    Q2 2022Quarterly · 2022-06-30SegmentWound Surgical66,094,000USD0001376339-23-000063
    Q1 2022Quarterly · 2022-03-31SegmentOther564,000USD0001376339-23-000015
    Q1 2022Quarterly · 2022-03-31SegmentRegenerative Medicine0USD0001376339-23-000015
    Q1 2022Quarterly · 2022-03-31SegmentWound Surgical58,330,000USD0001376339-23-000015
    FY 2021Yearly · 2021-12-31ProductHospital Site Of Service142,140,000USD0001376339-24-000009
    FY 2021Yearly · 2021-12-31ProductOther Site Of Service25,357,000USD0001376339-24-000009
    FY 2021Yearly · 2021-12-31ProductPrivate Office Site Of Service74,522,000USD0001376339-24-000009
    FY 2021Yearly · 2021-12-31SegmentOther3,079,000USD0001376339-23-000003
    FY 2021Yearly · 2021-12-31SegmentRegenerative Medicine16,596,000USD0001376339-23-000003
    FY 2021Yearly · 2021-12-31SegmentWound Surgical238,940,000USD0001376339-23-000003
    Q3 2021Quarterly · 2021-09-30SegmentOther860,000USD0001376339-22-000127
    Q3 2021Quarterly · 2021-09-30SegmentRegenerative Medicine76,000USD0001376339-22-000127
    Q3 2021Quarterly · 2021-09-30SegmentWound Surgical62,138,000USD0001376339-22-000127
    FY 2020Yearly · 2020-12-31ProductAdvanced Wound Care Tissue And Other192,566,000USD0001376339-22-000007
    FY 2020Yearly · 2020-12-31ProductAdvanced Wound Care Umbilical Cord Derived16,073,000USD0001376339-22-000007
    FY 2020Yearly · 2020-12-31ProductProduct And Service Other7,767,000USD0001376339-22-000007
    FY 2020Yearly · 2020-12-31ProductSection35131,828,000USD0001376339-22-000007
    FY 2020Yearly · 2020-12-31SegmentOther2,383,000USD0001376339-23-000003
    FY 2020Yearly · 2020-12-31SegmentRegenerative Medicine32,362,000USD0001376339-23-000003
    FY 2020Yearly · 2020-12-31SegmentWound Surgical213,489,000USD0001376339-23-000003

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.